Please try another search
By Ludwig Burger (Reuters) -Sanofi's first-quarter operating income fell 14.7% as currency effects and cheap competition to its multiple sclerosis drug Aubagio outweighed rising sales of...
(Reuters) - French drugmaker Sanofi (EPA:SASY) said on Thursday it would restructure the U.S. commercial operations for its vaccines and cut an undisclosed number of jobs. Sanofi would...
By Ludwig Burger (Reuters) -Sanofi's fourth-quarter operating income fell 5% as a weaker U.S. dollar and cheap competition to multiple sclerosis drug Aubagio outweighed rising sales of...
PARIS - Sanofi (EPA:SASY) (NASDAQ:SNY), the global healthcare leader, announced today that François-Xavier Roger will take over as Chief Financial Officer and join its Executive Committee starting...
PARIS - Sanofi (EPA:SASY) (NASDAQ:SNY), the French multinational pharmaceutical company, reported a solid performance for the fourth quarter of 2023, with a 9.3% growth in sales at constant...
(Reuters) -French healthcare company Sanofi (EPA:SASY) has agreed to buy U.S. biotech firm Inhibrx in a deal valued at up to $2.2 billion, bolstering its drug development portfolio with an...
By Brendan Pierson (Reuters) -GSK, Pfizer (NYSE:PFE) and other pharmaceutical companies are urging a judge in Delaware this week to find that evidence plaintiffs' lawyers want to use in about...
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review